Clearance Pathways and Tumor Targeting of Imaging Nanoparticles
Citations Over TimeTop 1% of 2015 papers
Abstract
A basic understanding of how imaging nanoparticles are removed from the normal organs/tissues but retained in the tumors is important for their future clinical applications in early cancer diagnosis and therapy. In this review, we discuss current understandings of clearance pathways and tumor targeting of small-molecule- and inorganic-nanoparticle-based imaging probes with an emphasis on molecular nanoprobes, a class of inorganic nanoprobes that can escape reticuloendothelial system (RES) uptake and be rapidly eliminated from the normal tissues/organs via kidneys but can still passively target the tumor with high efficiency through the enhanced permeability permeability and retention (EPR) effect. The impact of nanoparticle design (size, shape, and surface chemistry) on their excretion, pharmacokinetics, and passive tumor targeting were quantitatively discussed. Synergetic integration of effective renal clearance and EPR effect offers a promising pathway to design low-toxicity and high-contrast-enhancement imaging nanoparticles that could meet with the clinical translational requirements of regulatory agencies.
Related Papers
- → Avoiding the mononuclear phagocyte system using human albumin for mesoporous silica nanoparticle system(2017)44 cited
- → The Role of the Reticuloendothelial System in Viral Hepatitis(1988)1 cited
- [Effect of gelatin and dextran infusion on the reticuloendothelial system].(1979)
- → The Reticuloendothelial System and Erythropoiesis(1984)